VCNX Vaccinex Inc Company Short-Term Debt

Vaccinex - graphic logo of issuer VCNX

Immunotherapy developer Vaccinex, Inc. (VCNX) faces risks from global instability, which hinders cross-border testing and the protection of intellectual property. This chart reflects the current market value of 0.00, linking these challenges to partnerships with clinics combating brain degeneration. Processes are accelerating through the implementation of digital robots for data processing and automated antibody screening.

VCNX vaccinex.com Short-Term Debt (07/04/2022 - 12/28/2024)

Analytical breakdowns and data insights for company Vaccinex Inc (VCNX)

- current quotes and average value forecast:
Price Chart Vaccinex|VCNX - Average Forecast Price
- market capitalization data:
Market Value Vaccinex, Inc.|VCNX - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Vaccinex|VCNX - Total Stockholders' Equity|Market Capitalization to Book Value Ratio vaccinex.com|VCNX - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Vaccinex, Inc.|VCNX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Vaccinex, Inc.|VCNX - Aggregate Debt Obligations|Debts to Book Capitalization Vaccinex, Inc.|VCNX - Long-Term Debt Volume|Company Short-Term Debt Vaccinex|Quick Liquidity vaccinex.com
- earnings and multiples data:
VCNX - Net Income
General company analysis:Vaccinex (VCNX)
Flagship merchandise of vaccinex.com

This indicator measures the total volume of liabilities with a maturity of up to one year, reflecting current liquidity and default risk. Monitoring short-term liabilities allows for the identification of any accounting distortions, which is critical for Vaccinex, Inc. (VCNX), as the biotech's cash deficit when funding oncology drugs is often offset by equity issuance rather than borrowing.

Competitors of Vaccinex, Inc.

IBRX - Company Short-Term Debt|Short-Term Debt Immunocore Holdings|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt Zymeworks Inc.|Short-Term Debt tangotx.com TNGX|Company Short-Term Debts IOVA|Immatics NV (IMTX) - Short-Term Indebtedness|Xencor Corp - Company Current Liabilities|Compass Therapeutics Corp (CMPX) - Short-Term Debt|REPL: Company Current Liabilities|Company Short-Term Loans and Borrowings LYEL (lyell.com)|IPHA: Company Short-Term Debts|PYXS - Short-Term Debt Volume|Company Short-Term Debt Compugen Ltd|Company Current Liabilities IO Biotech Inc. (IOBT)|Company Short-Term Debt Sutro Biopharma, Inc. (STRO)|Company Current Liabilities minktherapeutics.com INKT|Werewolf Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Immix Biopharma Inc. IMMX|ALXO - Company Short-Term Debt|CUE (Cue Biopharma Inc.) - Company Short-Term Indebtedness|pdsbiotech.com (PDSB) - Company Short-Term Debt|Short-Term Debt Sonnet BioTherapeutics Holdings (SONN)|Company Current Liabilities MAIA|LIMN - Short-Term Indebtedness|Company Current Liabilities LVTX (LAVA Therapeutics N.V.)|Amount of Current Liabilities NXTC|Company Short-Term Debts LPTX (Leap Therapeutics)|Company Short-Term Loans and Borrowings INTS|Sensei Bio - Company Short-Term Debts|Short-Term Debt Theriva Biologics Inc|gritstonebio.com (GRTS) - Company Short-Term Debt|Kineta Corp - Company Short-Term Loans and Borrowings|NEXI (NexImmune, Inc.) - Company Short-Term Debts|Company Short-Term Debts Turnstone Biologics Corporation|Company Short-Term Debt Harpoon Therapeutics, Inc. (HARP)